Data / Dataset
Medicare Part D GLP-1 Formulary Coverage by State
How many Medicare Part D plans list each GLP-1 drug on their formulary, for 2026 and 2027 plans, nationally and by state, with tiers and prior authorization. Counted from CMS's own formulary files. Version 2026-10-15 (publish date of the newest CMS file used).
Download
Permanent URLs: https://medcostclear.com/data/medicare-part-d-glp1.csv and https://medcostclear.com/data/medicare-part-d-glp1.json. They always serve the latest version; the version is in the JSON file and the citation. 1,254 rows: plan year × drug × form × the U.S. and each state or territory.
License: CC BY 4.0 for our counts: reuse them freely with credit to MedCost Clear and a link to this page. CC BY 4.0 covers MedCost Clear's counts (the selection, arrangement and our calculations). The CMS files they are counted from are U.S. government works.
National figures
Share of all Part D plans in each CMS file whose formulary lists the drug (any form or strength). A listing means coverage for the drug's medically accepted uses under the plan's rules: Medicare Part D does not cover GLP-1 drugs used for weight loss,1 and plans may use prior authorization when they cover a drug only for certain conditions.2
| Drug | 2026 plans | 2027 plans | 2026 share | 2027 share |
|---|---|---|---|---|
| Wegovy | 175 of 5,496 | 5,492 of 5,492 | 3.2% | 100% |
| Zepbound | 26 of 5,496 | 7 of 5,492 | 0.5% | 0.1% |
| Ozempic | 5,445 of 5,496 | 5,492 of 5,492 | 99.1% | 100% |
| Mounjaro | 5,343 of 5,496 | 5,327 of 5,492 | 97.2% | 97.0% |
| Victoza or generic liraglutide | 1,129 of 5,496 | 842 of 5,492 | 20.5% | 15.3% |
| Saxenda | 0 of 5,496 | 0 of 5,492 | 0% | 0% |
| Foundayo | 0 of 5,496 | 0 of 5,492 | 0% | 0% |
- Wegovy: 175 of 5,496 plans (3.2%) list it for 2026; 5,492 of 5,492 (100%) for 2027.34 Why, with the method and a citation: Wegovy goes from 3% to 100% of Medicare Part D plans in 2027 (finding, Nov 15, 2026).
- Zepbound: 7 of 5,492 plans (0.1%) list it for 2027.4
Columns
| Column | Meaning |
|---|---|
| plan_year | Part D plan year the CMS file covers |
| drug | Drug: wegovy, zepbound, ozempic (injection and tablets, incl. the Rybelsus name), mounjaro, saxenda, foundayo, liraglutide (Victoza or generic 1.8 mg pens) |
| form | all (any form), injection or tablet |
| geography | US, or the two-letter code of a state, DC or territory |
| geography_name | Name of the state or territory |
| plans | Part D plans in the CMS file sold in this area (contract-plan-segment; plans CMS marks suppressed are left out; standalone PDPs and Medicare Advantage plans with drug coverage, incl. special needs plans) |
| plans_listing | Of those, plans whose formulary lists at least one form or strength of the drug |
| pct_listing | plans_listing / plans, percent, one decimal |
| pdp_plans | Standalone drug plans (PDP) among plans |
| pdp_listing | PDPs whose formulary lists the drug |
| mapd_plans | Medicare Advantage plans with drug coverage (MA-PD) among plans |
| mapd_listing | MA-PDs whose formulary lists the drug |
| tier_1 | Listing plans whose lowest tier for the drug is 1 |
| tier_2 | Same, tier 2 |
| tier_3 | Same, tier 3 |
| tier_4 | Same, tier 4 |
| tier_5 | Same, tier 5 |
| tier_6 | Same, tier 6 |
| with_prior_auth | Listing plans that require prior authorization for at least one listed form |
| with_quantity_limit | Listing plans with a quantity limit on at least one listed form |
| with_step_therapy | Listing plans with step therapy on at least one listed form |
| source_file | CMS file the row is counted from |
| source_released | Date CMS published that file on data.cms.gov |
| source_url | Download URL of the CMS file |
| source_sha256 | SHA-256 of our archived copy of the CMS file |
How it is made
- Source. CMS's "Monthly Prescription Drug Plan Formulary and Pharmacy Network Information" on data.cms.gov: for each plan year, the newest file in our archive. 2026: 2026_20260916.zip (2.29 GB, published Sep 23, 2026, SHA-256 51d0d4177f00458e…). 2027: 2027_20261008.zip (2.29 GB, published Oct 15, 2026, SHA-256 5f3bbe4e9ca29bce…). We use its plan information, basic drugs formulary and geographic locator files.
- Plans. Each contract-plan-segment in the plan information file, leaving out the ones CMS marks as suppressed: standalone drug plans (PDP) and Medicare Advantage plans with drug coverage, including special needs plans. A PDP counts in every state of its PDP region; a Medicare Advantage plan counts in each state where it serves at least one county (a regional PPO, in every state of its region).
- Drugs. A plan lists a drug when its formulary has at least one of the drug's RxNorm codes (RxCUIs, from NLM RxNav). Every matched formulary line is checked against the FDA NDC Directory: the brand from RxNorm and from the NDC must agree, and any line whose NDC belongs to semaglutide, tirzepatide, liraglutide or orforglipron must be matched. Combination products (insulin degludec and liraglutide) are left out. "Ozempic" includes Ozempic tablets and the Rybelsus name.
- Tier and rules. The lowest tier a plan gives the drug; prior authorization, quantity limit and step therapy count when at least one listed form has them.
- Limits. Plan counts, not people enrolled. A formulary listing is not a coverage decision for any person. Plans can cover drugs that are not on their list through exceptions, and can change their lists during the year. To compare plans for your ZIP code and drugs, use Medicare Plan Finder.
- The counts are rebuilt by code (scripts/build_partd.py) from our archived copies whenever we take in a new CMS file; the build stops if any check fails.
How this page is kept current
- FDA labels (DailyMed, openFDA), the NDC Directory and the drug shortage list: archived daily.
- CMS and Medicare.gov pages and fact sheets: archived daily.
- CMS Part D formulary files (which plans list which drugs): CMS publishes a new file monthly; we check for one weekly (Wednesdays). A person downloads and archives the new file, and the plan counts change when we rebuild from it.
- Every change in an archived copy is flagged for a person to check against the official page; the site is updated only after that check. Nothing is published automatically. Changes: price change log · mistakes: corrections · all sources: sources and update schedule.
Questions and corrections
Email [email protected] with the row and what the CMS file shows. Published by Blue Tree Technology LLC; see about us. Also see the GLP-1 Cost and Coverage Dataset.
Official sources for this page (4)
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”
CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors · as of Oct 17, 2026“Plans may also use prior authorization when they only cover a drug for certain medical conditions, but not others.”
Medicare.gov: Drug plan rules · as of Nov 15, 2026